BRANFORD, Conn. — Jun. 24, 2025– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the placement of its Platinum® Pro instrument at the Broad Institute. This collaboration aims to support scientific innovation across oncology, therapeutics, and other key areas of biomedical research. This placement expands […]

Simoa Technology Advances Earlier Disease Detection by Measuring Signature Biomarkers BILLERICA, MA – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that the HD-X Simoa Immunoassay Analyzer has received Class 1 Medical Device registration by the Ministry of Food and Drug Safety (MFDS) in South Korea through its regional distribution […]

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies Operating Structure and Enables Achievement of Adjusted EBITDA Break-Even Cash & Cash Equivalents of At Least $550 Million Expected at Close […]

Combines highly complementary proteomics expertise with Illumina’s industry-leading product innovation and global market reach Positions Illumina to achieve growth in a large, expanding market Illumina and SomaLogic have partnered in proteomics co-development since late 2021 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) announced today it has entered into a definitive agreement with Standard BioTools (NASDAQ: […]

A new open-access microbial phenotyping dataset will accelerate AI research and empower the global scientific community COVINA, Calif. – The Align Foundation, a nonprofit accelerating predictive biology through artificial intelligence (AI)-driven research infrastructure, today announced a collaboration with ATCC, the leading global nonprofit provider of microbial strains, cell lines, in vitro models, and standards, to […]

Aubagne, France Incoming Sartorius CEO Michael Grosse to become Chairman of the Board of Sartorius Stedim Biotech S.A. In its meeting, the Board of Directors of Sartorius Stedim Biotech S.A. (SSB) acknowledged the resignation of Dr. Joachim Kreuzburg as member of the Board as of June 30, 2025. As his replacement, the Board co-opted Dr. […]

USP employs mass photometry as key orthogonal method for empty/full characterization of AAV capsids Refeyn’s SamuxMP mass photometer for AAV analytics – used for characterizing the U.S. Pharmacopeia’s new adeno-associated virus (AAV) reference standards. For a high-resolution image, please contact omeea@alto-marketing.com Oxford, UK – Refeyn, the company behind pioneering mass photometry technology, announces that mass […]

Making clinical proteomics 100x more robust and 10x faster EuPA, Saint-Malo, France – Evosep , a global leader in robust, high throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML – OMICAssist Study— the world’s largest multi-omic precision medicine initiative, launched by P4ML alongside its strategic academic, health regulatory, and […]

GenBio AI Welcomes Emma Lundberg as Co-Founder and Chief Scientific Advisor PALO ALTO, Calif. — GenBio AI, a company building the World’s First AI-Driven Digital Organism (AIDO), is proud to announce that Dr. Emma Lundberg has formally joined the company as Co-Founder and Chief Scientific Advisor. An AI digital organism will redefine the future of […]

Additions to Company’s Range of Bioanalytical Antibodies and Reagents Enhances Bioanalysis and Antibody-Related Research HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to pertuzumab (Perjeta), guselkumab (Tremfya), […]